Information from Industry
Recent PCC Articles on Information from Industry
Commentary
Prescribing GLP-1 Receptor Agonists for Persons With Mental Disorders: Evidence-Based and Aspirational Targets
June 1, 2026
Evidence-based prescription of GLP-1 RAs in persons with serious mental illness and/or substance use disorders holds promise to improve their health and wellbeing and possibly reduce excess mortality.